3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
6
Prostatic Neoplasms
3
Neoplasms
3
Motor Activity
3
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Malnutrition
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Taste Disorders
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Rectal Neoplasms
1
Patient Compliance
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Metabolic Diseases
1
Lymphoma
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Hypertension
1
Hypercholesterolemia
1
Heart Failure
1
Heart Diseases
1
Esophageal Neoplasms
1
Interventions
relacorilant
3
Osilodrostat
2
sacubitril and valsartan sodium hydrate drug combination
1
lutetium Lu 177 dotatate
1
gallium Ga 68 dotatate
1
enzalutamide
1
bicalutamide
1
Urine Specimen Collection
1
Surveys and Questionnaires
1
Standard of Care
1
Receptors, Androgen
1
Nutrition Assessment
1
Leuprolide
1
Interviews as Topic
1
Holistic Health
1
Goserelin
1
Flutamide
1
Blood Specimen Collection
1
Biopsy
1
Amlodipine
1
Adrenalectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Nutrition Assessment
×
1 year
×
Clear all
NCT07126587
2025-10-30
HLA
University of North Carolina, Chapel Hill
Phase NA
Recruiting
120 enrolled